Stockreport

Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants

Foghorn Therapeutics Inc.  (FHTX) 
PDF CAMBRIDGE, Mass., May 20, 2024 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (“Foghorn”) (Nasdaq: FHTX) today announced the pricing of a registered direct offering of [Read more]